drugset

drugset / Trial / NCT03324139

Treatment of Intrauterine Growth Restriction With Low Molecular Heparin.

NCT03324139 ↗

Phase 3 Completed 48 enrolled Fundació Sant Joan de Déu Servicio de Asesoría a la Investigación y Logística SL · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

TREATMENT OF INTRAUTERINE GROWTH RESTRICTION WITH LOW MOLECULAR WEIGHT HEPARIN.

Timeline

Start: 2018-01-25
Primary completion: 2022-04-30
Completion: 2023-02-19

Publications

Mazarico E, Peguero A, Camprubi M, Rovira C, Gomez Roig MD, Oros D, Ibanez-Burillo P, Schoorlemmer J, Masoller N, Tassies MD, Figueras F. Study protocol for a randomised controlled trial: treatment of early intrauterine growth restriction with low molecular weight heparin (TRACIP). BMJ Open. 2018 Oct 23;8(10):e020501. doi: 10.1136/bmjopen-2017-020501.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bemiparin	Other / unclassified	3500 iu	Subcutaneous

Indications